Alexakis et al.
(0.456 g, 1.11 mmol). Purification by flash chromatography on
neutral alumina using toluene as eluent gave L7a as a white
foam in 30% yield (0.22 g). [R]D ) +171.8 (c ) 1.08 in CHCl3).
1H NMR (400 MHz, CDCl3), δ (ppm): 7.50 (d, 1H, J ) 2.3 Hz),
7.42 (d, 1H, J ) 2.3 Hz), 7.21 (d, 1H, J ) 2.5 Hz), 7.20-7.00
(m, 11H), 4.70-4.35 (brs, 2H), 1.65 (s, 9H), 1.38 (s, 18H), 1.14
(s, 9H). 13C NMR (100 MHz, CDCl3), δ (ppm): 168.2, 165.6,
147.9, 147.8(d), 145.8, 145.2, 140.2, 139.6, 132.9, 132.6 (d),
127.9, 126.9, 126.1, 124.1, 124.0, 35.6, 35.1, 34.6 (d), 31.8, 31.7,
31.6 (d), 30.8, 30.7, 19.9. 31P NMR (162 MHz, CDCl3), δ (ppm):
149.1.
(R,R)-(4,8-Bis(tr im eth ylsila n yl)-5,7-d ioxa -6-p h osp h a d -
ibenzo[a ,c]cyclohepten-6-yl)bis(1-phenylethyl)amine (L8a).
Ligand L8a was prepared according to the general procedure
using bis[(R)-phenylethyl]amine (0.225 g, 1.0 mmol) and B8
(0.331 g, 1.0 mmol). Purification by flash chromatography on
neutral alumina using toluene as eluent gave L8a as a white
foam in 12% yield (0.07 g). [R]20D ) +353.1 (c ) 1.02 in CHCl3).
1H NMR (400 MHz, CDCl3), δ (ppm): 7.54 (dd, 1H, J ) 7.3,
1.5 Hz), 7.50 (dd, 1H, J ) 7.3, 1.8 Hz), 7.41 (dd, 1H, J ) 7.6,
1.5 Hz), 7.31 (dd, 1H, J ) 7.8, 1.8 Hz), 7.25-7.19 (m, 4H), 7.11
(m, 8H), 4.54 (brs, 2H), 1.72-1.58 (m, 6H), 0.49 (s, 9H); 0.15
(s, 9H). 13C NMR (100 MHz, CDCl3), δ (ppm): 156.0 (d), 155.7,
155.6, 135.5, 135.1, 133.0, 131.7, 131.6, 131.0, 130.7(d), 128.4,
127.9, 127.8, 126.7, 124.0, 123.8, 53.2, 53.1, 1.1, 0.0, -0.1. 31P
NMR (162 MHz, CDCl3), δ (ppm): 149.4.
(R,R)-(4,8-Dia llyl-5,7-d ioxa -6-p h osp h a d iben zo[a ,c]cy-
cloh epten -6-yl)bis(1-ph en yleth yl)am in e (L9a). Ligand L9a
was prepared according to the general procedure using bis-
[(R)-phenylethyl]amine (0.266 g, 1.18 mmol) and B9 (0.315 g,
1.18 mmol). Purification by flash chromatography on neutral
alumina using toluene as eluent, gave L9a as a white foam in
64% yield (0.39 g). [R]D ) +248.8 (c ) 0.98 in toluene). 1H NMR
(300 MHz, CDCl3), δ (ppm): 7.40-7.00 (m, 16H), 6.10 (ddt, 1H,
J ) 17.0, 10.0, 6.8 Hz), 5.89 (ddt, 1H, J ) 17.1, 10.0, 6.6 Hz),
5.23 (dq, 1H, J ) 17.1, 1.7 Hz), 5.17 (dq, 1H, J ) 12.5, 1.7
Hz), 5.03 (dq, 1H, J ) 13.4, 1.7 Hz), 4.93 (dq, 1H, J ) 15.3,
1.7 Hz), 4.71 (m, 2H), 3.92 (dd, 1H, J ) 15.1, 6.6 Hz), 3.59
(dd, 1H, J ) 16.8, 6.9 Hz), 3.23 (d, 2H, J ) 6.6 Hz), 1.76 (d,
6H, J ) 6.4 Hz). 13C NMR (75 MHz, CDCl3), δ (ppm): 137.1,
137.0, 133.2, 132.3, 130.0, 129.9, 128.9, 128.8, 128.7, 128.4,
128.2, 127.2, 124.8, 124.2, 116.6, 116.1, 53.0, 52.9, 35.9, 34.9.
31P NMR (122 MHz, CDCl3), δ (ppm): 145.5.
(R,R)-(4,8-Dia llyl-5,7-d ioxa -6-p h osp h a d iben zo[a ,c]cy-
cloh ep ten -6-yl)bis(1-p h en ylp r op yl)a m in e (L9b). Ligand
L9b was prepared according to the general procedure using
bis[(R)-1-phenylpropyl)]amine (0.253 g, 1.0 mmol) and B9
(0.266 g, 1.0 mmol). Purification by flash chromatography on
neutral alumina using toluene as eluent gave L9b as a
colorless oil in 19% yield (0.11 g). [R]D ) +219.1 (c ) 1.08 in
CHCl3). 1H NMR (500 MHz, CDCl3), δ (ppm): 7.36-6.95 (m,
16H), 6.07 (ddt, 1H, J ) 16.9, 10.1, 6.8 Hz), 5.84(ddt, 1H, J )
13.6, 10.4, 6.5 Hz), 5.20 (dq, 1H, J ) 17.0, 1.7 Hz), 5.16 (dq,
1H, J ) 10.0, 1.8 Hz), 4.99 (dq, 1H, J ) 10.0, 1.8 Hz), 4.85
(dq, 1H, J ) 17.0, 1.9 Hz), 4.30 (m, 2H), 3.88 (dd, 1H, J )
15.2, 6.7 Hz), 3.59 (dd, 1H, J ) 15.3, 6.8 Hz), 3.11 (dd, 1H, AB
system, J ) 14.7, 6.3 Hz), 3.07 (dd, 1H, AB system J ) 14.6,
7.0 Hz), 2.34 (m, 2H), 2.10 (m, 2H), 0.81 (t, 6H, J ) 7.4 Hz).
13C NMR (125 MHz, CDCl3), δ (ppm): 149.4 (d), 148.8 (d), 136.7
(d), 132.8, 131.8, 131.7, 131.6, 130.8 (d), 129.6, 129.5, 129.0,
128.6, 128.5 (d), 128.2, 127.7, 127.6, 126.6, 125.3, 124.2, 123.8,
116.1, 115.6, 60.1, 35.3, 34.4, 29.7, 12.0, 11.8. 31P NMR (203
MHz, CDCl3), δ (ppm): 143.3.
4.05 (d, 1H, J ) 14.5 Hz), 3.50 (d, 1H, J ) 14.5 Hz), 3.30 (d,
1H, AB system, J ) 15.6 Hz), 3.23 (d, 1H, AB system, J )
15.6 Hz), 1.91-1.73 (m, 12H). 13C NMR (75 MHz, CDCl3), δ
(ppm): 150.0, 149.9, 149.2(d), 144.8, 144.5, 132.3, 132.2, 132.1,
132.0, 131.5, 130.8(d), 130.3, 130.2, 128.7, 128.6, 128.2, 127.9,
126.8, 124.3, 123.7, 112.0, 111.7, 52.5, 52.4, 39.5, 38.1, 22.9,
22.8, 22.6. 31P NMR (122 MHz, CDCl3), δ (ppm): 145.0.
(R,R)-[4,8-Bis(2-m eth ylallyl)-5,7-dioxa-6-ph osph adiben -
zo[a ,c]cycloh ep ten -6-yl]bis(1-p h en yleth yl)a m in e (L10b).
Ligand L10b was prepared according to the general procedure
using bis[(R)-1-phenyl-propyl)]amine (0.253 g, 1.0 mmol) and
B10 (0.294 g, 1.0 mmol). Purification by flash chromatography
on neutral alumina using toluene as eluent gave L10b as a
colorless oil in 32% yield (0.326 g). [R]D ) +215.4 (c ) 0.81 in
CHCl3). 1H NMR (300 MHz, CDCl3), δ (ppm): 7.26-6.99 (m,
16H), 4.75 (d, 1H, J ) 0.4 Hz), 4.66 (d, 1H, J ) 0.6 Hz), 4.65
(d, 1H, J ) 0.4 Hz), 4.31 (s, 1H), 4.19 (brs, 2H), 3.84 (d, 1H, J
) 8.7 Hz), 3.32 (d, 1H, J ) 8.7 Hz), 3.01 (d, 1H, AB system, J
) 9.3 Hz), 2.95 (d, 1H, AB system, J ) 9.4 Hz), 2.25-1.80 (m,
4H), 1.67 (s, 3H), 1.48 (s, 3H), 0.90-0.25 (m, 6H). 13C NMR
(75 MHz, CDCl3), δ (ppm): 149.8, 149.7, 149.1 (d), 144.9, 144.6,
132.2 (d), 131.9 (d), 131.3, 130.8 (d), 130.1, 128.6, 128.5, 127.7,
126.6, 124.1, 123.5, 111.8, 111.6, 50.7, 39.2, 37.8, 29.7, 22.7,
22.4, 11.8. 31P NMR (122 MHz, CDCl3), δ (ppm): 142.6.
(S,S)-(4,8-Dip r op yl-5,7-d ioxa -6-p h osp h a d ib en zo[a ,c]-
cycloh ep ten -6-yl)bis(1-p h en yleth yl)a m in e (L11a ). Ligand
L11a was prepared according to the general procedure using
bis[(S)-phenylethyl]amine (0.834 g, 3.7 mmol) and B11 (1.00
g, 3.7 mmol). Purification by flash chromatography on neutral
alumina using toluene as eluent gave L11a as a colorless oil
in 53% yield (1.034 g). [R]D ) -241.64 (c ) 1.05 in toluene).
1H NMR (400 MHz, CDCl3), δ (ppm): 7.36-7.11 (m, 16H), 4.70
(brs, 2H), 3.26-3.19 (m, 1H), 2.74-2.67 (m, 1H), 2.53 (t, 2H,
J ) 7.8 Hz), 1.83-1.57 (m, 10H), 1.08 (t, 2H, J ) 7.3 Hz), 0.93
(t, 2H, J ) 7.3 Hz). 13C NMR (100 MHz, CDCl3), δ (ppm): 150.0,
149.9, 149.2 (d), 144.8, 144.5, 132.3, 132.2, 132.1, 132.0, 131.5,
130.8 (d), 130.3, 130.2, 128.7, 128.6, 128.2, 127.9, 126.8, 124.3,
123.7, 112.0, 111.7, 52.5, 52.4, 39.5, 38.1, 22.9, 22.8, 22.6. 31P
NMR (162 MHz, CDCl3), δ (ppm): 145.0.
3-Eth ylcycloh exa n on e. Enantiomer separation by chiral
GC: Lipodex E (25 m, H2, 50 cm‚s-1). T: 60 °C. Rt ) 24.7 min
for enantiomer (R), and Rt ) 28.1 min for enantiomer (S).
3-Eth ylcycloh ep ta n on e. Enantiomer separation by chiral
GC: Lipodex E (25 m, H2, 50 cm‚s-1). T: 60 °C. Rt ) 45.6 min
for enantiomer (S), and Rt ) 47.2 min for enantiomer (R).
3-Eth ylcyclop en ta d eca n on e. Enantiomer separation by
chiral GC: Hydrodex â-3P, (25 m, H2, 50 cm‚s-1). T: 140 °C,
60 min; 1°/min. Rt ) 56.9 min for enantiomer (-)-(R), and Rt
) 58.2 min for enantiomer (+)-(S).
4-Eth yln on a n -2-on e. Enantiomer separation by chiral GC:
Lipodex E (25 m, H2, 50 cm‚s-1). T: 60 °C; 1°/min. Rt ) 17.8
min for enantiomer (S), and Rt ) 18.3 min for enantiomer (R).
4-P h en ylh exa n -2-on e. Enantiomer separation by chiral
GC: Lipodex E (25 m, H2, 50 cm‚s-1). T: 75 °C. Rt ) 39.9 min
for enantiomer (S), and Rt ) 41.8 min for enantiomer (R).
1,3-Dip h en ylp en ta n -2-on e. Enantiomer separation by
chiral SFC: Chiralcel OD-H, 0.25 m, 2% MeOH for 6 min, 3%
until 15 min, 2 mL‚min-1. Rt ) 5.6 min for enantiomer (+)-
(S), and Rt ) 6.3 min for enantiomer (-)-(R).
4-Eth yl-5-m eth ylh exa n on e. Enantiomer separation by
chiral GC: Lipodex E (25 m, H2, 50 cm‚s-1). T: 60 °C; 1°/min.
Rt ) 7.8 min for enantiomer (R), and Rt ) 8.3 min for
enantiomer (S).
(1-(Nitr om eth yl)p r op yl)ben zen e. Enantiomer separa-
tion: Lipodex E (25 m, H2, 50 cm‚s-1). T: 100 °C; 1 °C/min. Rt
) 17.0 min for enantiomer (S), and Rt ) 17.6 min for
enantiomer (R).
(R,R)-[4,8-Bis(2-m eth ylallyl)-5,7-dioxa-6-ph osph adiben -
zo[a ,c]cycloh ep ten -6-yl]bis(1-p h en yleth yl)a m in e (L10a ).
Ligand L10a was prepared according to the general procedure
using bis[(R)-phenylethyl]amine (0.225 g, 1.0 mmol) and B10
(0.294 g, 1.0 mmol). Purification by flash chromatography on
neutral alumina using toluene as eluent gave L10a as a
colorless oil in 53% yield (0.290 g). [R]D ) +249.1 (c ) 1.06 in
CHCl3). 1H NMR (300 MHz, CDCl3), δ (ppm): 7.46-7.21 (m,
16H), 4.95 (s, 1H), 4.87 (s, 2H), 4.76 (brs, 2H), 4.55 (s, 1H),
1-Met h yl-4-(1-(n it r om et h yl)p r op yl)b en zen e. Enanti-
omer separation by chiral GC: Lipodex E (25 m, H2, 50 cm‚s-1).
T: 100 °C; 1°/min. Rt ) 19.2 min for enantiomer (S), and Rt )
19.5 min for enantiomer (R).
5666 J . Org. Chem., Vol. 69, No. 17, 2004